U.S. STOCKS ON THE MOVE-Nike, Perrigo, Altria, CalAmp

The Day Ahead newsletter:

The Morning News Call newsletter:

Wall Street was mixed in volatile trading on Friday after two days of heavy losses, as concerns of slowing global growth and the threat of a U.S. government shutdown weighed on investors' minds.

The top three S&P 500 percentage gainers:

** Nike Inc , up 8.2 pct

** Carmax Inc , up 2.2 pct

** Foot Locker Inc , up 3.9 pct

The top S&P 500 percentage losers:

** Perrigo Co Plc, down 21.7 pct

** Conagra Brands Inc , down 2.9 pct

The top three NYSE percentage gainers:

** Sunlands Online Education Group, up 17.3 pct

** Companhia Energetica de Minas Gerais , up 4.3 pct

** Castlight Health Inc , up 6.6 pct

The top three NYSE percentage losers:

** Perrigo Co Plc, down 21.7 pct

** Invesco S&P SmallCap Quality ETF , down 20.5 pct

** Cambria Foreign Shareholder Yield ETF , down 13.4 pct

The top three Nasdaq percentage gainers:

** Obalon Therapeutics Inc , up 45.1 pct

** NF Energy Saving Corp , up 20.3 pct

** BioHiTech Global Inc, up 20.5 pct

The top three Nasdaq percentage losers:

** Wheeler Real Estate Investment Trust Inc , down 52.7 pct

** Wheeler Real Estate Investment Trust Inc , down 49.4 pct

** Piedmont Lithium Ltd, down 20 pct

** Obalon Therapeutics Inc: up 45.1 pct

Surges on FDA approval of imaging technology

** Nike Inc: up 8.2 pct

Shares rally after Q2 results beat on strong N.America online sales

** Walgreens Boots Alliance Inc: down 1.2 pct

Street View: Int'l, wholesale businesses continue to be a drag on Walgreens

** Perrigo Company Plc: down 21.7 pct

Falls after $1.9 bln tax bill from Ireland authorities

** Accenture Plc: down 1.0 pct

Street View: Accenture's "solid" qtr overshadowed by weak forecast

** Altria Group Inc: down 2.0 pct

Gets first 'sell' ratings in over a year on "rich" Juul deal

** KKR & Co Inc: up 1.3 pct

Telepizza gains 30 pct in two days on KKR takeover bid

** Proteostasis Therapeutics Inc: down 3.0 pct

Falls as co delays reporting cystic fibrosis trial data

** TRACON Pharmaceuticals Inc: down 27.7 pct

Tumbles after cancer drug fails mid-stage trial

** CalAmp Corp: down 12.5 pct

CalAmp Corp: Analysts cut PT on supply chain, macro concerns

The 11 major S&P 500 sectors:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.